Stockreport

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea [Read more]